loadpatents
Patent applications and USPTO patent grants for Kotick; Michael P..The latest application filed is for "7.beta.-arylalkyl-6.alpha., 7 .alpha.-oxymethylene-3-methoxy or 3-hydroxy-4, 5.alpha.-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans".
Patent | Date |
---|---|
7.beta.-Arylalkyl-6.alpha., 7 .alpha.-oxymethylene-3-methoxy or 3-hydroxy-4, 5.alpha.-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans Grant 4,443,605 - Kotick , et al. April 17, 1 | 1984-04-17 |
7.beta.-Arylalkyl-7.alpha.-methyl-6-oxo or 6.alpha.-hydroxy-3-methoxy or 3-hydroxy-4,5.alpha.-epoxy-17-methyl or 17-cycloalkyl-methylmorphinans Grant 4,440,932 - Kotick , et al. April 3, 1 | 1984-04-03 |
17-Cyclobutylmethyl-3-hydroxy-8.beta.-methyl-6-methylene-morphinane methanesulfonate Grant 4,334,071 - Kotick , et al. June 8, 1 | 1982-06-08 |
7,8 and 7-8 Substituted 4,5.alpha.-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them Grant 4,272,541 - Kotick , et al. June 9, 1 | 1981-06-09 |
7-Methyl-8.beta.-lower alkyl or 7-methyl-8-lower alkyl B/C cis or trans morphinan-6-one compounds and therapeutic method of treating pain employing them Grant 4,230,712 - Kotick , et al. October 28, 1 | 1980-10-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.